Director · Arcutis Biotherapeutics, Inc. · Common Stock
Side
SELL
Value
$279K
Shares
11.1K
Price
$25.03
Executed
Aug 27, 2026
Disclosed
Aug 28, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Aug 27 executedAug 28, 2026 disclosed
ARQT · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+5 / 15
1 other actor traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Curran Terrie filed this Form 4 reporting a open-market sale of ARQT on Aug 27, 2026. It became public on Aug 28, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Curran Terriecik:0001690298
Issuer
Arcutis Biotherapeutics, Inc.cik:0001787306
Revision history · 0
No field has changed since this record was first ingested.
